Synthesis, Characterization, and In-Vitro Evaluation of Silibinin-loaded PEGylated Niosomal Nanoparticles: Potential Anti-Cancer Effects on SW480 Colon Cancer Cells DOI Creative Commons
Urjwan Alali,

Maha Mohammed Kadhim Al-Tu’ma,

Ammar Fadhil Jawad

и другие.

Asian Pacific Journal of Cancer Prevention, Год журнала: 2024, Номер 25(7), С. 2539 - 2550

Опубликована: Июль 1, 2024

Colorectal cancer is a significant global health concern with high mortality rates. Silibinin compound derived from milk thistle anticancer properties and may be potential treatment option for colorectal cancer. Its poor solubility limits its clinical application, but various strategies, such as nanoparticle encapsulation, have shown promise. In this study, PEGylated niosomal drug delivery system was used to enhance the of silibinin, anti-proliferative effects were evaluated against human cell lines.

Язык: Английский

Niosomes: Composition, Formulation Techniques, and Recent Progress as Delivery Systems in Cancer Therapy DOI Creative Commons
Sergio Liga, Cristina Paul, Elena-Alina Moacă

и другие.

Pharmaceutics, Год журнала: 2024, Номер 16(2), С. 223 - 223

Опубликована: Фев. 4, 2024

Niosomes are vesicular nanocarriers, biodegradable, relatively non-toxic, stable, and inexpensive, that provide an alternative for lipid-solid carriers (e.g., liposomes). may resolve issues related to the instability, fast degradation, bioavailability, insolubility of different drugs or natural compounds. can be very efficient potential systems specific delivery anticancer, antioxidant, anti-inflammatory, antimicrobial, antibacterial molecules. This review aims present overview their composition, most common formulation techniques, as well recent utilizations in cancer therapy.

Язык: Английский

Процитировано

33

Targeted delivery of silibinin via magnetic niosomal nanoparticles: potential application in treatment of colon cancer cells DOI Creative Commons

Golchin Shafiei,

Davoud Jafari-Gharabaghlou,

Mahdi Farhoudi-Sefidan-Jadid

и другие.

Frontiers in Pharmacology, Год журнала: 2023, Номер 14

Опубликована: Июнь 27, 2023

Introduction: In recent years, various nanoparticles (NPs) have been discovered and synthesized for the targeted therapy of cancer cells. Targeted delivery increases local concentration therapeutics minimizes side effects. Therefore, NPs-mediated drug systems become a promising approach treatment cancers. As result, in current study, we aimed to design silibinin-loaded magnetic niosomes (MNNPs) investigate their cytotoxicity property colorectal cell treatment. Methods: MNPs ferrofluids were prepared encapsulated into (NIOs) by thin film hydration method. Afterward, morphology, size, chemical structure MNNPs evaluated using TEM, DLS, FT-IR techniques, respectively. Results Discussion: The distribution number was obtained at about 50 nm 70 with surface charge -19.0 mV TEM DLS analysis, Silibinin loading efficiency NIOs 90%, release pattern showed controlled maximum amount 49% 70%, within 4 h pH = 7.4 5.8, To effect, HT-29 cells treated drugs 24 48 MTT as well flow cytometry assays. Obtained results demonstrated promoted (5-fold decrease viability) compared pure silibinin (3-fold while had no significant cytotoxic effect on HEK-293 (normal line) cells, cellular uptake level line enhanced control group. conclusion, complex can be considered an efficient

Язык: Английский

Процитировано

22

Antioncogenic potential of probiotics: Challenges and future prospective DOI Open Access
Sourav Chattaraj, Debasis Mitra, Abhishek Chattaraj

и другие.

Indian Journal of Microbiology Research, Год журнала: 2023, Номер 10(1), С. 1 - 10

Опубликована: Май 1, 2023

Probiotics are beneficial microorganisms that have shown to possess numerous health benefits. Recently, there has been budding interests in the utilization of probiotics as a prospective weapon for cancer deterrence and management. The antioncogenic attributes were provided through various mechanisms such immune modulation, production anticancer compounds, regulation intestinal microbiota. current study shed light on probiotic strains explored their mechanisms. However, use prevention treatment also poses several challenges, including identification specific with most potent effects, optimal dosage duration treatment, hazards allied implementation live microorganisms. Additionally, heterogeneity types patients' microbiomes further complicate selection clinical applications. Hence, future should concentrate development alternative approaches microbial-derived components, genetically modified probiotics, synthetic biology overcome these challenges enhance potential probiotics.

Язык: Английский

Процитировано

19

Fabricating niosomal-PEG nanoparticles co-loaded with metformin and silibinin for effective treatment of human lung cancer cells DOI Creative Commons

Elnaz Salmani-Javan,

Davoud Jafari-Gharabaghlou,

Esat Bonabi

и другие.

Frontiers in Oncology, Год журнала: 2023, Номер 13

Опубликована: Авг. 17, 2023

Background Despite current therapies, lung cancer remains a global issue and requires the creation of novel treatment methods. Recent research has shown that biguanides such as metformin (MET) silibinin (SIL) have potential anticancer effect. As consequence, effectiveness MET SIL in combination against cells was investigated this study to develop an effective method. Methods Niosomal nanoparticles were synthesized via thin-film hydration method, field emission scanning electron microscopy (FE-SEM), Fourier transform infrared (FTIR), atomic force (AFM), dynamic light scattering (DLS) techniques used evaluate their physico-chemical characteristics. The cytotoxic effects free drug-loaded (NPs), well combination, on A549 assessed using MTT assay. An apoptosis test while under influence medication identify molecular mechanisms behind programmed cell death. With use cycle test, it determined whether pharmaceutical caused stop progressing. Additionally, qRT-PCR technique levels hTERT, BAX, BCL-2 gene expression after 48-h treatment. Results In cytotoxicity assay, growth inhibited by both SIL. Compared individual dramatically synergistically decreased IC50 values cells. Furthermore, produced lower better anti-proliferative effect Real-time PCR results showed hTERT significantly reduced lines treated with compared single treatments (p< 0.001). Conclusion It is anticipated nano-niosomal-formed would improve outcomes therapeutic efficiency

Язык: Английский

Процитировано

14

G Protein-Coupled Receptor 75 (GPR75) As a Novel Molecule for Targeted Therapy of Cancer and Metabolic Syndrome DOI Creative Commons

Mohammad Reza Dashti,

Fatemeh Gorbanzadeh,

Davoud Jafari-Gharabaghlou

и другие.

Asian Pacific Journal of Cancer Prevention, Год журнала: 2023, Номер 24(5), С. 1817 - 1825

Опубликована: Май 1, 2023

In recent years, molecular targeted therapy has attracted more attention from researchers due to its high efficiency and fewer side effects. Researchers are attempting find specific ways treat diseases. It been found that there different targets for the treatment of diseases such as cancer, obesity, metabolic syndrome. is important a potential target in order lessen effects current treatments. G Protein-coupled receptors (GPCRs) large family transmembrane proteins expressed many organs, leading activation internal signal transduction cascades through binding ligands, including neurotransmitters, peptides, lipids. Due critical role GPCRs cells, it could be target. protein-coupled receptor 75 (GPR75) novel member GPCR an diseases, Until now, three ligands have detected GPR75, 20-HETE, CCL5, RANTES. Recent studies suggest triggers signaling pathways PI3K/Akt RAS/MAPK, aggressive phenotype prostate cancer cells. Additionally, RAS/MAPK activate NF-κB, which significant various development proliferation, migration, apoptosis. The findings indicate inhibiting GPR75 humans leads increase insulin sensitivity glucose tolerance, well reduction body fat storage. According these discoveries, drug syndrome, cancer. this review, we aimed discuss therapeutic impact obesity underscore possible pathways.

Язык: Английский

Процитировано

12

Advancing therapeutic efficacy: nanovesicular delivery systems for medicinal plant-based therapeutics DOI
Mohamed J. Saadh, Mohammed Ahmed Mustafa, Sanjay Kumar

и другие.

Naunyn-Schmiedeberg s Archives of Pharmacology, Год журнала: 2024, Номер 397(10), С. 7229 - 7254

Опубликована: Май 3, 2024

Язык: Английский

Процитировано

5

Co-delivery of artemisinin and metformin via PEGylated niosomal nanoparticles: potential anti-cancer effect in treatment of lung cancer cells DOI

Salah Jaafar Abdulkareem,

Davoud Jafari-Gharabaghlou,

Mahdi Farhoudi-Sefidan-Jadid

и другие.

DARU Journal of Pharmaceutical Sciences, Год журнала: 2024, Номер 32(1), С. 133 - 144

Опубликована: Янв. 3, 2024

Язык: Английский

Процитировано

4

Beneficial microbiome and diet interplay in early-onset colorectal cancer DOI
Zhengyuan Zhou, Linda Kleis, Ana Depetris-Chauvin

и другие.

EMBO Molecular Medicine, Год журнала: 2024, Номер 17(1), С. 9 - 30

Опубликована: Дек. 9, 2024

Язык: Английский

Процитировано

4

New insights into polysaccharide-based nanostructured delivery systems in breast cancer: Possible application of antisense oligonucleotides in breast cancer therapy DOI

Fahimeh Shayegh,

Zeynep Türk, Arta Armani

и другие.

International Journal of Biological Macromolecules, Год журнала: 2024, Номер 272, С. 132890 - 132890

Опубликована: Июнь 1, 2024

Язык: Английский

Процитировано

4

Liposomes and Niosomes: New trends and applications in the delivery of bioactive agents for cancer therapy DOI
Helena de Almeida Cerqueira Kodel,

Paria Alizadeh,

Samad Nejad Ebrahimi

и другие.

International Journal of Pharmaceutics, Год журнала: 2024, Номер unknown, С. 124994 - 124994

Опубликована: Ноя. 1, 2024

Язык: Английский

Процитировано

4